tiprankstipranks
Advertisement
Advertisement

CYTK Stock Latest News

Cytokinetics Earnings Call Highlights MYQORZO Surge
Company AnnouncementsCytokinetics Earnings Call Highlights MYQORZO Surge
4d ago
CYTK
Hold Rating Reaffirmed as Patent Dispute Adds Risk; $85 Price Target Remains Unchanged
PremiumRatings
Hold Rating Reaffirmed as Patent Dispute Adds Risk; $85 Price Target Remains Unchanged
6d ago
CYTK
Cytokinetics price target raised to $110 from $95 at Barclays
PremiumThe Fly
Cytokinetics price target raised to $110 from $95 at Barclays
6d ago
CYTK
Cytokinetics price target raised to $103 from $97 at JPMorgan
PremiumThe Fly
Cytokinetics price target raised to $103 from $97 at JPMorgan
6d ago
CYTK
Cytokinetics Files Patent Suit to Protect MYQORZO Franchise
PremiumCompany Announcements
Cytokinetics Files Patent Suit to Protect MYQORZO Franchise
10d ago
8K
CYTK
Cytokinetics price target raised to $112 from $106 at Truist
PremiumThe FlyCytokinetics price target raised to $112 from $106 at Truist
13d ago
CYTK
Cytokinetics price target raised to $85 from $83 at BofA
Premium
The Fly
Cytokinetics price target raised to $85 from $83 at BofA
16d ago
CYTK
Cytokinetics price target raised to $112 from $102 at Needham
Premium
The Fly
Cytokinetics price target raised to $112 from $102 at Needham
16d ago
CYTK
Cytokinetics price target lowered to $112 from $117 at RBC Capital
PremiumThe Fly
Cytokinetics price target lowered to $112 from $117 at RBC Capital
16d ago
CYTK
Cytokinetics: Strong MYQORZO Launch and Upcoming Catalysts Support Buy Rating and Unchanged $140 Price Target
PremiumRatings
Cytokinetics: Strong MYQORZO Launch and Upcoming Catalysts Support Buy Rating and Unchanged $140 Price Target
16d ago
CYTK
Cytokinetics price target raised to $110 from $105 at Citizens
PremiumThe Fly
Cytokinetics price target raised to $110 from $105 at Citizens
16d ago
CYTK
Cytokinetics reports Q2 EPS ($1.50), consensus ($1.60)
PremiumThe Fly
Cytokinetics reports Q2 EPS ($1.50), consensus ($1.60)
17d ago
CYTK
Cytokinetics (CYTK) Q2 Earnings Cheat Sheet
PremiumPre-EarningsCytokinetics (CYTK) Q2 Earnings Cheat Sheet
19d ago
CYTK
Opus, Cytokinetics, Albertsons, Weatherford, Paysign Shock
Premium
Weekend Updates
Opus, Cytokinetics, Albertsons, Weatherford, Paysign Shock
22d ago
ACI
IRD
Cytokinetics announces MHRA authorization for Myqorzo
Premium
The Fly
Cytokinetics announces MHRA authorization for Myqorzo
24d ago
CYTK
Travelers, TransDigm, Cytokinetics, Global-e, Crescent Shock Moves
PremiumWeekend Updates
Travelers, TransDigm, Cytokinetics, Global-e, Crescent Shock Moves
29d ago
TDG
TRV
Larimar, Cytokinetics, Itau, Global-e, Immunovant Shake-Up
PremiumWeekend Updates
Larimar, Cytokinetics, Itau, Global-e, Immunovant Shake-Up
1M ago
CYTK
GLBE
Cytokinetics price target lowered to $117 from $119 at RBC Capital
PremiumThe Fly
Cytokinetics price target lowered to $117 from $119 at RBC Capital
2M ago
CYTK
CYTK, PRME, DOCS, WBD, LQDA Trending With Analysts
PremiumWeekend Updates
CYTK, PRME, DOCS, WBD, LQDA Trending With Analysts
2M ago
WBD
CYTK
Adobe downgraded, Roblox upgraded: Wall Street’s top analyst calls
PremiumThe FlyAdobe downgraded, Roblox upgraded: Wall Street’s top analyst calls
2M ago
U
ON
Cytokinetics upgraded to Buy from Neutral at UBS
Premium
The Fly
Cytokinetics upgraded to Buy from Neutral at UBS
2M ago
CYTK
Cytokinetics price target raised to $118 from $100 at Mizuho
Premium
The Fly
Cytokinetics price target raised to $118 from $100 at Mizuho
2M ago
CYTK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >